Cargando…

Parkinson's Disease: General Features, Effects of Levodopa Treatment and Future Directions

Detalles Bibliográficos
Autores principales:	Freire, Marco Aurélio M., Santos, José Ronaldo
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031077/ https://www.ncbi.nlm.nih.gov/pubmed/21120063 http://dx.doi.org/10.3389/fnana.2010.00146

Ejemplares similares

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease
por: Carvalho, Miguel M., et al.
Publicado: (2017)

Differential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
por: Graef, Susanne, et al.
Publicado: (2010)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
por: He, Xiaoqin, et al.
Publicado: (2022)

Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
por: Krishna, Rakhee, et al.
Publicado: (2014)

Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson’s Disease
por: Ruonala, Verneri, et al.
Publicado: (2018)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Levodopa in Parkinson’s Disease: Current Status and Future Developments
por: Tambasco, Nicola, et al.
Publicado: (2018)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease
por: Guridi, J., et al.
Publicado: (2012)

Effects of levodopa on gut bacterial antibiotic resistance in Parkinson’s disease rat
por: Sheng, Shuo, et al.
Publicado: (2023)

Morphologic brain network predicts levodopa responsiveness in Parkinson disease
por: Xie, Yongsheng, et al.
Publicado: (2023)

Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
por: Perez-Pardo, Paula, et al.
Publicado: (2018)

Levodopa Enhances Reward Learning but Impairs Reversal Learning in Parkinson's Disease Patients
por: Moustafa, Ahmed A.
Publicado: (2011)

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2017)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
por: Yang, Changwei, et al.
Publicado: (2020)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
por: Muddapu, Vignayanandam Ravindernath-Jayashree, et al.
Publicado: (2022)

Psychotic symptoms in the context of levodopa treatment in Parkinson’s Disease: clinical feature or iatrogenesis?
por: Costa, M.L., et al.
Publicado: (2022)

Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
por: Youn, Jinyoung, et al.
Publicado: (2022)

Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
por: Pieterman, Marcus, et al.
Publicado: (2018)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Levodopa Changes Functional Connectivity Patterns in Subregions of the Primary Motor Cortex in Patients With Parkinson’s Disease
por: Shen, Yang, et al.
Publicado: (2020)

Alterations of PAC-based resting state networks in Parkinson’s disease are partially alleviated by levodopa medication
por: Mertiens, Sean, et al.
Publicado: (2023)

MR Tractography-Based Targeting and Physiological Identification of the Cuneiform Nucleus for Directional DBS in a Parkinson’s Disease Patient With Levodopa-Resistant Freezing of Gait
por: Chang, Stephano J., et al.
Publicado: (2021)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
por: Aygun, Dursun, et al.
Publicado: (2016)

Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
por: Bispo, Ana Gabrielle, et al.
Publicado: (2023)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson’s Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2017)

Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions
por: di Biase, Lazzaro, et al.
Publicado: (2023)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Mathematical Insights into the Effects of Levodopa
por: Reed, Michael C., et al.
Publicado: (2012)

Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson’s Disease
por: Mogharbel, Bassam Felipe, et al.
Publicado: (2022)

A Mathematical Model of Levodopa Medication Effect on Basal Ganglia in Parkinson's Disease: An Application to the Alternate Finger Tapping Task
por: Baston, Chiara, et al.
Publicado: (2016)

Continuous levodopa for advanced Parkinson’s disease
por: Lundqvist, Christofer
Publicado: (2007)

Mortality in Levodopa-Treated Parkinson's Disease
por: Morgan, John C., et al.
Publicado: (2014)

Feature visualization and classification for the discrimination between individuals with Parkinson’s disease under levodopa and DBS treatments
por: Machado, Alessandro R. P., et al.
Publicado: (2016)

Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson’s Disease: Current Limitations and Future Directions
por: Guglietti, Bianca, et al.
Publicado: (2021)

Striatal Gα(olf)/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Goto, Satoshi
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mfdc9dsbcnthmsh50rbj980b47